Comments on the new ESC guidelines on pacemaker and cardiac resynchronization therapy [Kommentar zu den neuen ESC-Leitlinien zur Schrittmacher- und kardialen Resynchronisationstherapie]

被引:0
|
作者
Israel C.W. [1 ]
Bänsch D. [2 ]
Breithardt O. [3 ]
Butter C. [4 ]
Klingenheben T. [5 ]
Kolb C. [6 ]
Lemke B. [7 ]
Wiegand U. [8 ]
Nowak B. [9 ]
机构
[1] Klinik für Innere Medizin – Kardiologie, Diabetologie und Nephrologie, Evangelisches Krankenhaus Bielefeld, Burgsteig 13, Bielefeld
[2] Klinik und Poliklinik für Innere Medizin I – Kardiologie, Universitätsmedizin Rostock, Rostock
[3] Abteilung für Rhythmologie, Herzzentrum Leipzig, Universitätsklinik, Leipzig
[4] Abteilung Kardiologie, Immanuel Klinikum Bernau, Herzzentrum Brandenburg, Bernau
[5] Praxis für Kardiologie und Ambulante Herzkatheter-Kooperation Bonn, Bonn
[6] Klinik für Herz- und Kreislauferkrankungen, Abteilung für Elektrophysiologie, Fakultät für Medizin, Deutsches Herzzentrum München, Technische Universität München, München
[7] Klinik für Kardiologie und Angiologie, Klinikum Lüdenscheid, Lüdenscheid
[8] Klinik für Kardiologie, Rhythmologie und Elektrophysiologie, Sana-Klinikum Remscheid, Remscheid
[9] Medizinisches Versorgungszentrum, CCB, Cardioangiologisches Centrum Bethanien, Frankfurt am Main
来源
Der Kardiologe | 2015年 / 9卷 / 1期
关键词
Atrioventricular block; Bradycardia; Cardiac pacemaker; Remote monitoring; Telemedicine;
D O I
10.1007/s12181-014-0650-4
中图分类号
学科分类号
摘要
The guidelines of the European Society of Cardiology (ESC) on cardiac pacing and cardiac resynchronization therapy (CRT) from 2007 have been updated and comprehensively edited to reflect new study results on the indications for device implantation and to facilitate the application in routine daily practice. In sick sinus syndrome, threshold values for the minimum duration of the pause and bradycardia heart rates have been omitted since they may have different implications depending on structural heart disease, vagal tone and physical fitness. Atrioventricular (AV) block is divided into intrinsic (organic) and extrinsic (functional, e. g. during high vagal tone) conduction disorders. While the indications for pacemaker implantation are simplified and broader than before for intrinsic AV blocks, they are stricter than before for extrinsic, vagally-induced pauses and bradycardia. Instead of implanting a pacemaker, an improved correlation of symptoms to bradycardia by prolonged monitoring is recommended and vagally-induced asymptomatic pauses (sinus arrest or AV block) are considered for pacemaker therapy only if they exceed 6 s. For patients in sinus rhythm (permanent or intermittent), systems involving the atrium are recommended. In AV block and reduced left ventricular function CRT should be considered. To establish the indications for CRT in heart failure, the most important parameter is the bundle branch block morphology and for non-left bundle branch block morphology a QRS > 150 ms was downgraded to class IIa and for a QRS of 120–150 ms to class IIb. The use of systems compatible with magnetic resonance imaging (MRI) and remote monitoring should generally be considered. The new guidelines provide valuable help, the indications on routine pacemaker therapy are simpler, well-founded and more easily related to patients. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:35 / 45
页数:10
相关论文
共 50 条
  • [2] ESC-Leitlinien 2021 zur Schrittmacher- und ResynchronisationstherapieWas gibt es Neues?ESC guidelines 2021 on cardiac pacing and cardiac resynchronization therapyWhat’s new?
    Julia Vogler
    Ahmad Keelani
    Anna Traub
    Roland Richard Tilz
    Herz, 2022, 47 (1) : 31 - 40
  • [3] Erratum zu: Schrittmacher- und kardiale ResynchronisationstherapieKommentar zu den Leitlinien (2021) der ESCErratum to: Pacemaker and cardiac resynchronization treatmentComments on the 2021 ESC guidelines
    Christian Butter
    Lars Eckardt
    Carsten W. Israel
    Christian Andreas Perings
    Daniel Steven
    Martin Stockburger
    Die Kardiologie, 2022, 16 (6) : 455 - 455
  • [4] Schrittmacher- und kardiale ResynchronisationstherapieKommentar zu den Leitlinien (2021) der ESCPacemaker and cardiac resynchronization treatmentComments on the 2021 ESC guidelines
    Christian Butter
    Lars Eckardt
    Carsten W. Israel
    Christian Andreas Perings
    Daniel Steven
    Martin Stockburger
    Die Kardiologie, 2022, 16 (5) : 383 - 390
  • [6] Comments on the new ESC guidelines on pacemaker and cardiac resynchronization therapy
    Israel, C. W.
    Baensch, D.
    Breithardt, O.
    Butter, C.
    Klingenheben, T.
    Kolb, C.
    Lemke, B.
    Wiegand, U.
    Nowak, B.
    KARDIOLOGE, 2015, 9 (01): : 35 - 45
  • [7] Kommentar zu den ESC-Leitlinien zur Device-Therapie bei Herzinsuffizienz 2010Commentary on the 2010 ESC guidelines on device therapy in heart failure
    C.W. Israel
    S.D. Anker
    G. Hasenfuß
    Der Kardiologe, 2012, 6 (1): : 5 - 11
  • [8] Kommentar zu den Leitlinien (2018) der ESC und EACTS zur MyokardrevaskularisationComments on the 2018 ESC/EACTS Guidelines on Myocardial Revascularization
    F.-J. Neumann
    R. A. Byrne
    D. Sibbing
    A. Kastrati
    N. Frey
    T. Doenst
    J. Gummert
    A. M. Zeiher
    V. Falk
    Der Kardiologe, 2019, 13 (4): : 181 - 192
  • [9] Kommentar zu den Leitlinien (2018) der ESC und EACTS zur MyokardrevaskularisationComments on the 2018 ESC/EACTS Guidelines on Myocardial Revascularization
    F.-J. Neumann
    R. A. Byrne
    D. Sibbing
    A. Kastrati
    N. Frey
    T. Doenst
    J. Gummert
    A. M. Zeiher
    V. Falk
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2019, 33 (6) : 415 - 424
  • [10] Kommentar zu den ESC-Leitlinien „Guidelines on Diagnosis and Management of Acute Pulmonary Embolism“Commentary on the ESC Guidelines on Diagnosis and Management of Acute Pulmonary Embolism
    S. Konstantinides
    U. Janssens
    E. Mayer
    G. Hasenfuß
    Der Kardiologe, 2009, 3 (4): : 272 - 282